… of nanoparticle-basedcancerimmunotherapies are … of immunotherapeutics (such as whole cancer cell vaccines, immune … of a few immunotherapies for more efficient cancer inhibition …
Y Hu, W Zhang, X Chu, A Wang, Z He, CL Si… - International Journal of …, 2023 - Elsevier
… that target DCs in anticancer immunotherapy (Fig. 1). We firmly believe that polymer-based DC-targeting immunotherapy may be the next breakthrough in cancerimmunotherapy. …
… In this review we discuss and analyze the current nanoparticle-basedimmunotherapy … on nanoparticle-based delivery systems that improve the effectiveness of PC immunotherapy. We …
… Immune stimulation can be useful for vaccination and for cancerimmunotherapy. NP-based … NP-based immunotherapy is a very promising strategy for cancer treatment [Citation40]. …
… nanoparticle-based cytokine delivery system for the delivery of multiple immunotherapeutic … In the case of adjuvant delivery, the nanoparticle-based delivery systems with fine-tuned …
Although recent successes in clinical trials are strengthening research focused on cancer immunology, the poor immunogenicity and off-target side effects of immunotherapeutics …
YM Park, SJ Lee, YS Kim, MH Lee, GS Cha… - Immune …, 2013 - synapse.koreamed.org
… Here, we review current nanoparticle-based platforms in the efficacious delivery of vaccines in cancerimmunotherapy. [… Nanoparticlebased delivery platforms hold great potential for …
… of patients with advanced non-small cell lung cancer (NSCLC). However, only a minority of … superior immunotherapy. Herein, we report on a nanoparticle-basedimmunotherapy termed …
Immunotherapeutic approaches for treating cancer overall have been receiving a considerable amount of interest due to the recent approval of several clinical formulations. Among the …